BAY 61-3606 dihydrochloride

BAY 61-3606 dihydrochloride is an inhibitor of SYK used in studies of Immune Signaling and Apoptosis. It is especially relevant in angiogenesis, apoptosis, and cancer models, where defined compound exposure can be linked to cytokine-mediated signaling and inflammatory effector responses and caspase-associated cell-death signaling and survival decisions.

By inhibiting SYK, BAY 61-3606 dihydrochloride can be used to examine cytokine-mediated signaling and inflammatory effector responses and caspase-associated cell-death signaling and survival decisions. The kinase annotation adds relevance to biochemical kinase assays, phospho-signaling studies, and selectivity profiling, together with downstream-response mapping in the same experimental setting. In angiogenesis, apoptosis, and cancer models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving SYK
• Pathway perturbation studies connected to Immune Signaling and Apoptosis
• Concentration-response inhibition and target-dependence studies
• Biochemical kinase assays, phospho-signaling studies, and selectivity profiling

Overall, BAY 61-3606 dihydrochloride is appropriate when a defined chemical perturbant is needed to connect SYK with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in angiogenesis, apoptosis, and cancer models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.